Irreversible and reversible pulpitis teeth Oral Health Dental
Conditions
Interventions
The power calculation revealed that a sample size using 50 volunteer patients in each supplementary technique (three arms) will have 80% power to detect an effect size of 0.57 in a continuous outcome
Sponsors
The Newcastle Upon Tyne Hospitals NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 16 years of age and over 2. Good medical health 3. Any maxillary tooth with irreversible pulpitis and an asymptomatic vital tooth on the opposite site of the arch to act as an internal control of pulp tester function
Exclusion criteria
Exclusion criteria: 1. Allergies or sensitivities to amide-type local anaesthetics or other ingredients in the anaesthetic solutions 2. Inability to provide informed consent 3. Relevant medical history, which may compromise the welfare of the patient (e.g. unstable angina) or which may compromise data collection (e.g. facial paraesthesia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of maxillary infiltration anaesthesia with articaine and lidocaine (both with epinephrine) in patients suffering from irreversible pulpitis in a maxillary permanent tooth. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of supplementary injections such as palatine injections, repeat infiltration, intraligamentary, or intraosseous anaesthesia for securing pain control in patients suffering from maxillary irreversible pulpitis tooth. | — |
Countries
United Kingdom
Outcome results
None listed